Cambridge University Press Effective Treatments in Psychiatry Peter Tyrer and Kenneth R. Silk Excerpt More information
|
|
- June Jackson
- 5 years ago
- Views:
Transcription
1 Organic disorders
2
3 1 Delirium Based on Delirium by Laura Gage and David K. Conn in Effective Treatments in Psychiatry, Cambridge University Press, 2008 Introduction Delirium needs treatment for both its causes and manifestations, as, if ignored, it is associated with excessive periods of hospitalization or early mortality. The common causes include infection, drug intoxication, renal or hepatic insufficiency, vascular disease affecting the brain, and (often forgotten) electrolyte disturbance. The main interventions are environmental and pharmacological and the symptoms on which they are focused are agitation, overactivity, restlessness, and other behavioural disturbance, and psychotic symptoms such as hallucinations, delusions, and paranoid reconstruction of the world. As might be expected, randomized controlled trials are very difficult to carry out in this population as the manifestations of delirium are acute and cannot be ignored, and most of the evidence of efficacy of interventions is based on less convincing models. Non-pharmacological interventions Delirium is very common in hospitalized patients, particularly after surgery and other interventions, and providing a consistent environment with the right level of stimulation has long been thought to avoid or reduce manifestations of delirium. Only one randomized trial has been carried out of 31 patients following 3
4 4 Organic disorders open heart surgery in an intensive care unit (Budd & Brown, 1974). Patients randomized to a specific reorientation procedure, focusing on time, place, person, and physical status, given by intensive care nurses, showed fewer symptoms of delirium, had significantly fewer postoperative complications, and were discharged from hospital an average of 4 days earlier compared with a control group of patients who did not receive this intervention but who had standard care. Other nonrandomized studies have supported these findings (Chatham, 1978; Williams et al., 1985; Milisen et al., 2001). A review by Cole et al. (1996) concluded that systematic interventions to stabilize the environment and offer support were more effective with older surgical patients compared with patients on medical units. A recent Cochrane Review of multidisciplinary team interventions in patients with chronic cognitive impairment concluded that although nine controlled trials were identified for possible inclusion in the review, only one (Budd & Brown, 1974) met the inclusion criteria. Despite the presumptive evidence from other studies they concluded that delirium is currently managed empirically and that there was no evidence in the literature to support changes to current practice (Britton & Russell, 2004). Despite the relative absence of good data supporting controlled environmental interventions the American Psychiatric Association still recommend them because of wide clinical experience and, perhaps more importantly, their lack of adverse effects (American Psychiatric Association, 1999). This has increased in importance as the technology of intensive care has improved and environments become less homely. Patients with delirium can become overstimulated by the excessive noise in such units. Similarly, if stimulation is too low delirium can also become more likely. Pharmacological interventions Typical antipsychotic drugs Only one randomized controlled trial has compared typical antipsychotics in delirium. Breitbart et al. (1996) compared the effectiveness of chlorpromazine, haloperidol, and lorazepam in hospitalized patients with AIDS. All included met diagnostic criteria for delirium and scored 13 or more on the delirium rating scale (DRS). Two hundred and forty-four patients were included and 30 of these subsequently developed delirium and were randomized to one of the three study medications. The efficacy of intervention was similar for haloperidol and
5 Delirium 5 chlorpromazine and improvement was noted within the first 24 hours. Those patients allocated to lorazepam developed major side effects but the mean daily dosage of the drug (4.6 mg) was much higher than the usual dosage. As there was no placebo control arm, haloperidol or chlorpromazine may not have performed better than no intervention. All other studies in the published literature are small and have weak methodology so no conclusions can be drawn. A combination of benzodiazepines and haloperidol was compared in a naturalistic study by Menza et al. (1988). It was noted that those who received the haloperidol and benzodiazepines had fewer extrapyramidal symptoms than those who received haloperidol alone (with haloperidol given intravenously). Atypical antipsychotic drugs Olanzapine Olanzapine has been compared with haloperidol in a randomized controlled trial involving 73 patients. Patients satisfying DSM-IV criteria for delirium were randomized to haloperidol or olanzapine and the results showed no difference in the reduction of delirium over time. However, intravenous haloperidol as a rescue drug was used in 36% of those taking olanzapine on the first day of delirium and 18% of patients on the second day; this clearly contaminated interpretation of the findings. No other controlled trials have been carried out with olanzapine but reports suggest that it is efficacious and with few extrapyramidal effects (Sipahimalani & Masand, 1998). Risperidone A randomized double-blind trial of risperidone and haloperidol in the treatment of delirium (Han & Kim, 2004) showed no difference between the two drugs but only 24 patients entered the trial. However, those treated with haloperidol had a 75% response compared with 42% on risperidone. Rather better results have been understandably found in open studies (Horikawa et al., 2003; Parellada et al., 2004). It is difficult to make any firm conclusions about risperidone on the basis of these data. Quetiapine, ziprasidone, and remoxipride Open studies have suggested that these three drugs may have some value in the treatment of delirium (Robertson et al., 1996; Schwartz & Masand, 2000; Kim et al., 2003) but no definite conclusions can be drawn from them. Cholinesterase inhibitors As these drugs are commonly used in the treatment of dementia and
6 6 Organic disorders behavioural disturbance (see following chapters) it is not surprising that they, mainly donezepil and rivastigmine, have been used in the treatment of delirium. One small trial with 15 patients treated with rivastigmine (1.5 mg increasing to 3.0 mg/ day) showed shorter duration of delirium compared with placebo (Overshott et al., 2010), but another larger trial of rivastigmine 4.5 mg daily versus placebo (Gamberini et al., 2009) showed no benefit for the active drug. Benzodiazepines Although benzodiazepines reduce the risk of extrapyramidal symptoms (Menza et al., 1998) they sometimes promote cognitive impairment. This problem has only been marked in the study by Breitbart et al. (1996), which used high doses. Nevertheless, a recent Cochrane Review concluded no adequately controlled trials could be found to support the use of benzodiazepines in the treatment of nonalcohol withdrawal-related delirium among hospitalized patients, and at this time benzodiazepines cannot be recommended for the control of this condition (Lonergan et al., 2009). Mianserin This atypical antidepressant drug has been compared with haloperidol in 40 patients diagnosed with delirium using DSM-IV criteria (Nakamura et al., 1997). Again there was no difference in the improvement between the groups with 7 out of 10 patients improving on these treatments. Mianserin was given in a dose of between 10 mg and 60 mg a day and caused oversedation in two patients. Electroconvulsive therapy This treatment has been given in the past for delirium but is highly unlikely to be given nowadays. Nevertheless, an old study based on retrospective chart review suggested that patients receiving ECT together with conventional treatment had a shorter duration of delirium symptoms than those just receiving the treatment without ECT (Dudley & Williams, 1972). Guidelines The American Psychiatric Association Practice Guidelines for the Treatment of Patients with Delirium (American Psychiatric Association, 1999) supports the use of antipsychotics as the main pharmacological treatment of choice in delirium. Haloperidol has been identified as the most appropriate and it is suggested that the dosage should be started at 1 2 mg every 2 to 4 hours as needed (with half of this dosage in the elderly) and, when problems become more severe, the
7 Table 1.1 Evidence base for interventions in delirium Treatment Form of treatment Psychiatric disorder Level of evidence to test efficacy Comments Environmental manipulation of those at risk Typical antipsychotic drugs Haloperidol in oral, intramuscular or intravenous Reorientation procedures Delirium Ib One randomized trial gave form Chlorpromazine Atypical antipsychotic drugs Risperidone Quetiapine Remoxipride Delirium of all types including hypoactive delirium Delirium with or without dementia results supportive of this intervention Ib Effective, but the extrapyramidal and sedative effects may Ib III III preclude use Limited evidence, most favouring risperidone Atypical antipsychotic drugs Olanzapine Delirium of all types III Alleged similar efficacy to Benzodiazepines Lorazepam Delirium of all types Benzodiazepines and antipsychotic drugs but specifically effective in alcohol withdrawal delirium (see p. 52) haloperidol but studies inadequate to confirm Ib Probably effective in lower dosage, but adds to cognitive impairment in higher dosage Haloperidol and lorazepam Delirium III A favoured combination, but no good evidence in support
8 Table 1.1 (cont.) Treatment Form of treatment Psychiatric disorder Level of evidence to test efficacy Comments Benzodiazepines and opioids Diazepam, flunitrazepam, and pethidine Prevention of postoperative delirium IIb Some evidence of efficacy but needs replication 5-HT 3 receptor antagonists Odansetron Postoperative delirium III Only tested in open study Cholinesterase inhibitors Donepezil Rivastigmine Mixed delirium Ib Two randomized trials of rivastigmine in delirium, one positive (small trial) and the other negative (large trial) Tetracyclic antidepressants Mianserin Delirium of all types IIa May be equivalent in efficacy to haloperidol but limited evidence Psychostimulants Methylphenidate Hypoactive delirium III One study (before after) with limited conclusions Electroconvulsive therapy (ECT) Bilateral Delirium tremens in particular III Case reports only
9 Delirium 9 drug can be given by intravenous injection of 10 mg followed by intravenous infusion of up to 5 10 mg per hour. However, this is based on only one case series and has come under criticism (Tauscher et al., 2000). The National Institute for Health and Clinical Excellence has also developed a guideline for prevention and treatment and the recommendations for prevention of delirium for patients at risk are to ensure that people at risk of delirium are cared for by a team of healthcare professionals who are familiar with the person at risk (National Clinical Guidance Centre for Acute and Chronic Conditions, 2010). For those diagnosed with delirium the recommendations are to (i) identify and manage the possible underlying cause or combination of causes and (ii) ensure effective communication and reorientation and provide reassurance for people diagnosed with delirium, with family, friends, and carers when available, who may be able to help with this. If these non-pharmacological approaches are ineffective, the guideline suggests the practitioner should consider giving short-term (for 1 week or less) haloperidol or olanzapine. This guideline is not fundamentally different from the American one and does not alter the basic recommendations. Summary Delirium is an acute psychiatric event and it is understandable that there are few randomized controlled trials comparing forms of treatment, and none which includes placebo control. This complicates interpretation of management but there is a large body of data that supports (i) sensitive environmental adjustment and reorientation (for prevention and initial management) and (ii) pharmacological intervention with antipsychotic drugs (for delirium unresponsive to environmental interventions). The other drugs considered for the treatment of delirium are not to be used without very careful consideration after first-line treatments have failed (Table 1.1).
10 2 Management of behavioural and psychological symptoms of dementia and acquired brain injury Based on Management of behavioural and psychological symptoms of dementia and acquired brain injury by Joel Sadavoy, Krista L. Lanctôt and Shoumitro Deb in Effective Treatments in Psychiatry, Cambridge University Press, 2008 Introduction Some might find the title and terminology of this chapter a little unusual, but it comes from the guidelines of the International Psychogeriatric Association (1998, 2002) which brought together this group of symptoms under the heading of Behavioural and Psychological Symptoms in Dementia (BPSD). Although it is not a diagnostic term it is nonetheless useful when it comes to managing individual patients, as it is the symptoms and manifest behaviour that the clinician is called upon to treat irrespective of their diagnostic background. As often these behaviours are acute in presentation, drug treatment is used most frequently in their management. These disturbances are very common and occur almost always at some point in a long dementing illness. Rubin et al. (1988) describes seven types of these behavioural problems memory disturbance, physical violence and hitting, incontinence, catastrophic reactions, suspiciousness, and accusatory behaviour. These are clearly disturbing symptoms and can often lead to major problems in hospitals, care homes, 10
Delirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care
Delirium A Plan to Reduce Use of Restraints David Wensel DO, FAAHPM Medical Director Midland Care Objectives Define delirium Describe pathophysiology of delirium Understand most common etiologies Define
More informationThe Agitated. Older Patient: old. What To Do? Michelle Gibson, MD, CCFP Presented at Brockville General Hospital Rounds, May 2003
Focus on CME at Queen s University Focus on CME at Queen s University The Agitated The Older Patient: What To Do? Michelle Gibson, MD, CCFP Presented at Brockville General Hospital Rounds, May 2003 Both
More informationDEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.
DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that
More informationDrug induced delirium
Drug induced delirium Knut Erik Hovda, MD, PhD, FACMT, FEAPCCT The Norwegian CBRNe Centre of Medicine Department of Acute Medicine Oslo University hospital Content 1. Introduction 2. Risk factors 3. Prevalence
More informationPRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist
PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines
More informationDelirium. Assessment and Management
Delirium Assessment and Management Goals and Objectives Participants will: 1. be able to recognize and diagnose the syndrome of delirium. 2. understand the causes of delirium. 3. become knowledgeable about
More informationPsychotropic Strategies Handout Package
Psychotropic Strategies Handout Package Psychotropic Strategies Learning Objectives Utilize all clinical information available Assess the patient s overall condition this is essential Basic Principles
More informationDelirium Monograph - Update, Spring 2014
Delirium Monograph - Update, Spring 2014 Since publication of the APM monograph on Delirium in January 2012, three structured reviews have been published adding data relevant to the practice of identification,
More informationBehavioral and Psychological Symptoms of dementia (BPSD)
Behavioral and Psychological Symptoms of dementia (BPSD) Chris Collins - Old Age Psychiatrist, Christchurch chris.collins@cdhb.health.nz Approaching BPSD: the right mindset Assessment Non-drug management
More informationUp to 90% of people with dementia experience
Focus on CME at the University of Calgary Getting Aggressive with Dementia Adrienne Cohen, MD, BSc, FRCPC Presented at Behaviour Problems in the Elderly, video-audio conference, 2003 Up to 90% of people
More informationManagement of Delirium in the Elderly Patients: A Review of Evidence
Review Article imedpub Journals http://journals.imedpub.com Journal of Drug Abuse 2471-853X DOI: 10.21767/2471-853X.10006 Abstract Management of Delirium in the Elderly Patients: A Review of Evidence Delirium
More informationManaging Delirium: The best way to achieve clarity (of mind) Tim Walsh. Professor of Critical Care, Edinburgh University
Managing Delirium: The best way to achieve clarity (of mind) Tim Walsh Professor of Critical Care, Edinburgh University Lecture Plan: a route to clarity What is delirium? Why is delirium important? Step
More informationAntipsychotic Medications
TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood
More informationAppendix D: Included Studies adverse effects review
DELIRIUM APPENDICES (Draft for Consultation) Appendix D: Included Studies adverse effects review Table D1: Studies directly comparing two antipsychotic agents in delirium Author Study design Setting Age
More informationDelirium. Dr. John Puxty
Delirium Dr. John Puxty Learning Objectives By the end of the workshop participants will be able to: Appreciate the main diagnostic criteria for delirium. Describe common risk factors, causes and main
More informationDelirium. Approach. Symptom Update Masterclass:
Symptom Update Masterclass: Delirium Jason Boland Senior Clinical Lecturer and Honorary Consultant in Palliative Medicine Wolfson Centre for Palliative Care Research Hull York Medical School University
More informationDelirium. Quick reference guide. Issue date: July Diagnosis, prevention and management
Issue date: July 2010 Delirium Diagnosis, prevention and management Developed by the National Clinical Guideline Centre for Acute and Chronic Conditions About this booklet This is a quick reference guide
More informationDelirium in Hospital Care
Delirium in Hospital Care Dr John Puxty 1 Learning Objectives By the end of the workshop participants will be able to: Appreciate the main diagnostic criteria for delirium. Describe common risk factors,
More informationDELIRIUM. Approach and Management
DELIRIUM Approach and Management By Dr. K.S. Jacob, Professor of Psychiatry and Dr. Anju Kuruvilla, Professor of Psychiatry, Christian Medical College, Vellore. Based on a chapter in the book Psychiatric
More informationDisclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA
Disclosure Speaker Bureaus Pfizer Forest Norvartis Grant Support Pan American Health Organization/WHO NIA HRSA How Common is Psychosis in Alzheimer s Disease? Review of 55 studies 41% of those with Alzheimer
More informationSafe and Effective Use of. Psychotropic Drugs. Introduction. Psychotropic Drugs. Jun NAKAMURA
Psychotropic Drugs Safe and Effective Use of Psychotropic Drugs JMAJ 47(6): 259 264, 2004 Jun NAKAMURA Professor, Department of Psychiatry, School of Medicine, University of Occupational and Environmental
More informationDelirium in Cancer: Psychopharmacologic Management
Delirium in Cancer: Psychopharmacologic Management William Breitbart, MD Professor and Chief, Psychiatry Service Memorial Sloan-Kettering Cancer Center New York, New York Delirium in Patients with Cancer
More informationInterprofessional Webinar Series
Interprofessional Webinar Series Assessment and Management of Delirium Pauline Lesage, MD, LLM Physician Educator MJHS Institute for Innovation in Palliative Care Disclosure Slide Pauline Lesage, MD, LLM,
More informationEvidence-Based Treatment of Delirium in Patients With Cancer William Breitbart and Yesne Alici
Published Ahead of Print on March 12, 2012 as 10.1200/JCO.2011.39.8784 The latest version is at http://jco.ascopubs.org/cgi/doi/10.1200/jco.2011.39.8784 JOURNAL OF CLINICAL ONCOLOGY R E V I E W A R T I
More informationWhat Is Delirium? Causes of Delirium
1 What Is Delirium? Delirium is a condition that develops quickly (usually over hours or days) and involves changes in consciousness, attention, cognition (thinking and reasoning), and perception. An individual
More information11/11/2016. Disclosures. Natural history of BPSD. Objectives. Assessment of BPSD. Behavioral Management of Persons with Alzheimer s Disease
Disclosures Behavioral Management of Persons with Alzheimer s Disease Wisconsin Association of Medical Directors November 17, 2016 Art Walaszek, M.D. Professor of Psychiatry UW School of Medicine & Public
More informationLearning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016
Terminal Restlessness Dr. Christopher Churchill St. Cloud VA Health Care System EC&R Service Line Director & Medical Director Hospice & Palliative Care March 31, 2016 Learning Objectives Different Terminology
More informationUSING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE?
USING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE? Mugdha Thakur, MD Associate Professor of Psychiatry and Behavioral Sciences Duke University
More information( delirium ) 15%- ( extrapyramidal syndrome ) risperidone olanzapine ( extrapyramidal side effect ) olanzapine ( Delirium Rating Scale, DRS )
2005 6 48-52 Olanzapine 30% ( delirium 5%- Haloperidol ( extrapyramidal syndrome risperidone ( extrapyramidal side effect ( Delirium Rating Scale, DRS ( Delirium ( Olanzapine ( Delirium Rating Scale, DRS
More informationg Prevention, Diagnosis, and Management in Palliative Care
8/3/2012 Improving p g Prevention, Diagnosis, g and Management in Palliative Care MN Rural Palliative Care Networking Group Quarterly Education Session June 27,2012 Sandra W. Gordon-Kolb, MD, MMM, CPE
More informationDiagnosis and treatment of acute agitation and aggression in patients with schizophrenia and bipolar disorder: evidence for the efficacy of atypical
Diagnosis and treatment of acute agitation and aggression in patients with schizophrenia and bipolar disorder: evidence for the efficacy of atypical antipsychotics 1 Abstract Acute agitation and aggression
More informationPharmacological Treatment of Aggression in the Elderly
Pharmacological Treatment of Aggression in the Elderly Howard Fenn, MD Adjunct Clinical Associate Professor Department of Psychiatry and Behavioral Sciences Stanford University Self-Assessment Question
More informationGUIDELINES FOR THE MANAGEMENT OF DELIRIUM IN ADVANCED CANCER
GUIDELINES FOR THE MANAGEMENT OF DELIRIUM IN ADVANCED CANCER 14.1 GENERAL PRINCIPLES Delirium can be defined as: A transient organic brain syndrome characterised by the acute onset of disordered arousal
More informationSiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA. [compatible with NICE guidance]
SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA [compatible with NICE guidance] Medicines Management Committee August 2002 For review August 2003 Rationale The SiGMA algorithm
More informationDebra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017
Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic
More informationTREATING DELIRIUM A QUICK REFERENCE GUIDE FOR PSYCHIATRISTS
TREATING DELIRIUM A QUICK REFERENCE GUIDE FOR PSYCHIATRISTS T he Quick Reference Guide for the treatment of delirium is a summary and synopsis of the American Psychiatric Association s Practice Guideline
More informationSilvia Duong, 1,2 Kam-Tong Yeung, 1 and Feng Chang 1,3. 1. Introduction
Aging Research Volume 2015, Article ID 570410, 6 pages http://dx.doi.org/10.1155/2015/570410 Research Article Intramuscular Olanzapine in the Management of Behavioral and Psychological Symptoms in Hospitalized
More informationGuidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care
Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia
More informationCognitive disorders. Dr S. Mashaphu Department of Psychiatry
Cognitive disorders Dr S. Mashaphu Department of Psychiatry Delirium Syndrome characterised by: Disturbance of consciousness Impaired attention Change in cognition Develops over hours-days Fluctuates during
More informationOrganization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit
Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit Problem: For dementia patients, antipsychotic medications are prescribed
More informationDELIRIUM IN ICU: Prevention and Management. Milind Baldi
DELIRIUM IN ICU: Prevention and Management Milind Baldi Contents Introduction Risk factors Assessment Prevention Management Introduction Delirium is a syndrome characterized by acute cerebral dysfunction
More informationasenapine 5mg, 10mg sublingual tablet (Sycrest ) SMC No. (762/12) Lundbeck Ltd
asenapine 5mg, 10mg sublingual tablet (Sycrest ) SMC No. (762/12) Lundbeck Ltd 10 February 2012 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS
More informationPRESCRIBING GUIDELINES
The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors
More informationPsychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD
Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences
More informationPharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital
Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital with thanks to Jonathan Cavan for his input Aims Define BPSD and common symptoms
More informationDelirium. Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta
Delirium Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta Overview A. Delirium - the nature of the beast B. Significance of delirium C. An approach
More informationSymptom Management Pocket Guides: DELIRIUM
Symptom Management Pocket Guides: DELIRIUM August 2010 DELIRIUM Page Considerations. 1 Assessment 2 Diagnosis. 3 Non-Pharmacological treatment 3 Pharmacological treatment. 5 Mild Delirium... 6 Moderate
More informationResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Research Journal of Pharmaceutical, Biological and Chemical Sciences Prescribing Pattern of Antipsychotics In A Tertiary Care Hospital, Salem: A Retrospective Study. B Arul 1 *, E Manivannan 2, R Kothai
More informationANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good?
ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good? STEPHANIE M. OZALAS, PHARMD, BCPS, BCGP VA MARYLAND HEALTH CARE SYSTEM BALTIMORE, MD DISCLOSURES Off-label use of medications will be
More informationPsychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan
Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan Pretest 1. Appropriate target symptoms for emergency room medication treatment
More information5 older patients become delirious every minute
Management of Delirium: Nonpharmacologic and Pharmacologic Approaches Sharon K. Inouye, M.D., M.P.H. Professor of Medicine Beth Israel Deaconess Medical Center Harvard Medical School Milton and Shirley
More informationPsychosis and Agitation in Dementia
Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, University
More informationBEHAVIORAL PROBLEMS IN DEMENTIA
BEHAVIORAL PROBLEMS IN DEMENTIA CLINICAL FEATURES Particularly as dementia progresses, psychiatric symptoms may develop that resemble discrete mental disorders such as depression or mania The course and
More informationThe Maudsley Prescribing Guidelines in
The Maudsley Prescribing Guidelines in 11th Edition David Taylor Director of Pharmacy and Pathology South London and Maudsley NHS Foundation Trust; Professor King's College London, London, UK Paton Chief
More informationDelirium. Dr. Lesley Wiesenfeld. Deputy Psychiatrist in Chief, Mount Sinai Hospital. Dr. Carole Cohen
Delirium Dr. Lesley Wiesenfeld Deputy Psychiatrist in Chief, Mount Sinai Hospital Dr. Carole Cohen Department of Psychiatry, University of Toronto and Sunnybrook Health Sciences Centre Case Study Mrs B
More informationManagement of Severe Agitation
Management of Severe Agitation Key Points 1. The management of the severely agitated or violent patient embraces psychological, physical and pharmacological approaches. 2. Psychological methods focus on
More informationCritical Care Pharmacological Management of Delirium
Critical Care Pharmacological Management of Delirium Policy Title: in the Critical Care Unit Executive Summary: This policy provides guidance Pharmacological Management of delirium in the Critical Care
More informationPsychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan
Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan Pretest 1. Which of the following conditions is LEAST likely to benefit from emergency
More informationManagement of Agitation in Dementia. Kimberly Triplett Ferguson, MS4
Management of Agitation in Dementia Kimberly Triplett Ferguson, MS4 Objectives 1. Review recommended evaluation of agitated patients with dementia. 2. Discuss evidence concerning nonpharmacologic management.
More informationManagement of Behavioral Problems in Dementia
Management of Behavioral Problems in Dementia Ghulam M. Surti, MD Clinical Assistant Professor Department of Psychiatry and Human Behavior Warren Alpert Medical School of Brown University Definition of
More informationBIOLOGICAL TREATMENT IN PSYCHIATRY. PTE ÁOK Dept.of Psychiatry Pécs
BIOLOGICAL TREATMENT IN PSYCHIATRY PTE ÁOK Dept.of Psychiatry Pécs 1 SGA effects pharmacokinetic effect chemical strucrure Receptor block D2 5-HT2 α1 H-1 M Selectíve DA (D2D3) antagonists Benzamids Amisulpiride
More informationDelirium. Delirium. Delirium Etiology and Pathophysiology. Fall 2018
Three most common cognitive problems in adults 1. (acute confusion) 2. Dementia 3. Depression These problems often occur together Can you think of common stimuli for each? 1 1 State of temporary but acute
More informationPDFlib PLOP: PDF Linearization, Optimization, Protection. Page inserted by evaluation version
PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version www.pdflib.com sales@pdflib.com doi:10.1111/j.1479-8301.2007.00215.x PSYCHOGERIATRICS 2008; 8: 32 37 REVIEW
More informationRole of Clozapine in Treatment-Resistant Schizophrenia
Disease Management and Treatment Strategies Elkis H, Meltzer HY (eds): Therapy-Resistant Schizophrenia. Adv Biol Psychiatry. Basel, Karger, 2010, vol 26, pp 114 128 Role of Clozapine in Treatment-Resistant
More informationDelirium in the Elderly
Delirium in the Elderly ELITE 2017 Liza Genao, MD Division of Geriatrics Why should we care about delirium? It is: common associated with high mortality associated with increased morbidity Very much under-recognized
More informationAntipsychotics Detect, Select, Effect (P.I.E.C.E.S. 6 th Ed)
Antipsychotics Detect, Select, Effect (P.I.E.C.E.S. 6 th Ed) CLeAR Webinar February 14, 2014 Paula Diaz (Pharm) Carol Ward MD Carol Ward Tertiary Mental Health IHA Hillside Centre (Acute Tertiary Mental
More informationAntipsychotics in the Treatment of Delirium: A Systematic Review
Antipsychotics in the Treatment of Delirium: A Systematic Review Dallas P. Seitz, M.D.; Sudeep S. Gill, M.D., M.Sc., F.R.C.P.C.; and Louis T. van Zyl, M.D., M.Med., F.R.C.P.C. Objective: Antipsychotics
More informationResubmission. Scottish Medicines Consortium
Scottish Medicines Consortium Resubmission aripiprazole 5mg, 10mg, 15mg, 0mg tablets; 10mg, 15mg orodispersible tablets; 1mg/mL oral solution (Abilify ) No. (498/08) Bristol-Myers Squibb Pharmaceuticals
More informationHaloperidol and risperidone in the treatment of delirium and its subtypes
Eur. J. Psychiat. Vol. 25, N. 2, (59-67) 2011 Keywords: Delirium; Treatment; Haloperidol; Risperidone; Antipsychotics. Haloperidol and risperidone in the treatment of delirium and its subtypes Soenke Boettger*
More informationSummary of Delirium Clinical Practice Guideline Recommendations Post Operative
Summary of Delirium Clinical Practice Guideline Recommendations Post Operative Intensive Care Unit Clinical Practice Guideline for Postoperative Clinical Practice Guidelines for the Delirium in Older Adults;
More informationPresented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD
Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Define BPSD and review the spectrum of associated symptoms Review pharmacologic and non-pharmacologic treatments for BPSD Evaluate
More informationAppendix N: Research recommendations
Appendix N: recommendations N.1 First-line treatment of motor symptoms recommendation 1 Interventions What is the effectiveness of initial levodopa monotherapy versus initial levodopa-dopamine agonist
More informationTreatment of behavioral and psychological symptoms of dementia: a systematic review
Psychiatr. Pol. 2016; 50(4): 679 715 PL ISSN 0033-2674 (PRINT), ISSN 2391-5854 (ONLINE) www.psychiatriapolska.pl DOI: http://dx.doi.org/10.12740/pp/64477 Treatment of behavioral and psychological symptoms
More informationPSYCHOTROPIC SOLUTIONS
PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Key Senate Committee Recommendations: All RACF
More informationClinical Perspective on Conducting TRD Studies. Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark
Clinical Perspective on Conducting TRD Studies Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark Overview of Presentation Treatment-Resistant Depression (TRD)
More information1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER
1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER 1.1 GENERAL PRINCIPLES There are many causes of agitation in palliative care patients, which makes recommendations for treatment difficult.
More informationUse of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia
Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia Aine Leen, Kieran Walsh, David O Sullivan, Denis O Mahony, Stephen Byrne, Margaret Bermingham Pharmaceutical Care Research Group,
More informationNuplazid. (pimavanserin) New Product Slideshow
Nuplazid (pimavanserin) New Product Slideshow Introduction Brand name: Nuplazid Generic name: Pimavanserin Pharmacological class: Atypical antipsychotic Strength and Formulation: 17mg; tablets Manufacturer:
More informationPsychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI
Regional Affective Disorders Service Psychopharmacology Northumberland, Tyne and Wear NHS Trust Hamish McAllister-Williams Reader in Clinical Psychopharmacology Department of Psychiatry, RVI Intro NOT
More informationThe prevalence of dementia increases from. Pharmacological management of behavioural disturbance in patients with dementia. Dementia.
Dementia Pharmacological management of behavioural disturbance in patients with dementia Management of behavioural disturbance in the setting of dementia can be challenging. There are many potential causes
More informationMental Health Emergencies
Mental Health Emergencies P atients with emergencies related to mental health may present in a diverse number of ways and pose a major challenge to clinicians with respect to diagnosis and management.
More informationTreatment of Schizophrenia
Treatment of Schizophrenia Conduct comprehensive assessment and use measurement-based care as found in the Principles of Practice (review pages 4-7). Most importantly assess social support system (housing,
More informationHome Care and Hospice Association of New Jersey Annual Conference 2017
Home Care and Hospice Association of New Jersey Annual Conference 2017 I D E N T I F I C A T I O N A N D M A N A G E M E N T O F D E L I R I U M E L I Z A B E T H M A G E R - O C O N N O R A C H P N DR
More informationCare of the Acutely Agitated Patient. Objectives. Agitation Defined
Care of the Acutely Agitated Patient James C. Hardy, MD Assistant Professor of Emergency Medicine Department of Emergency Medicine, UCSF Dealing with combative patients is one of the most difficult challenges
More informationManual of Clinical Psychopharmacology
Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School
More informationThe place for treatments of associated neuropsychiatric and other symptoms
The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public
More informationTREATING DELIRIUM. A Quick Reference Guide
TREATING DELIRIUM A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Delirium, originally published in May 1999. A guideline watch, summarizing significant developments
More informationCognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics
Cognitive enhancers PINCH ME Anticholinergic burden BPSD Agitation, Aggression and antipsychotics 2 types Cholinesterase inhibitors licensed for mild to moderate AD Donepezil Galantamine Rivastigmine also
More informationFormulary and Clinical Guideline Document Pharmacy Department Medicines Management Services
Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services VIOLENCE, AGGRESSION OR SEVERE BEHAVIOURAL DISTURBANCE Introduction During an acute episode or illness, some
More informationBehavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.
Behavioral Issues in Dementia March 27, 2014 Dylan Wint, M.D. OVERVIEW Key points Depression Definitions and detection Treatment Psychosis Definitions and detection Treatment Agitation SOME KEY POINTS
More informationICU Delirium: Recognition, Management and Long-Term Outcomes
ICU Delirium: Recognition, Management and Long-Term Outcomes Sandy Staveski RN, PhD, CPNP-AC/PC, CNS Assistant Professor, Nurse Scientist Cincinnati Children s Hospital Medical Center Research in Patient
More informationAntipsychotics in Bipolar
Use of Second-Generation Antipsychotics in Bipolar Disorder: A Practical Guide Flavio Guzman, MD Editor Psychopharmacology Institute This practical guide is an update on the use of second-generation antipsychotics
More informationCauses of Transient Incontinence. Geriatrics: Urinary Incontinence, Dementia, and Delirium. Classification of Established Incontinence
Causes of Transient Geriatrics: Urinary, Dementia, and Delirium Carla Zeilmann, PharmD, BCPS St. Louis College of Pharmacy Therapeutics 3 Fall 2003 D delirium I infection A atrophic urethritis and vaginitis
More informationMedication alternatives for behavioural disturbance
Neurology 13 Medication alternatives for behavioural disturbance Many patients with dementia will in the later stages develop distressing behavioural symptoms. Antipsychotics are commonly used to treat
More informationClass Update: Oral Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationDelirium in the ICU: Prevention and Treatment. Delirium Defined Officially. Delirium: Really Defined. S. Andrew Josephson, MD
Delirium in the ICU: Prevention and Treatment S. Andrew Josephson, MD Director, Neurohospitalist Service Medical Director, Inpatient Neurology June 2, 2011 Delirium Defined Officially (DSM-IV-TR) criteria
More informationDelirium. A Geriatric Syndrome. Jonathan McCaleb, MD, CMD, HMDC UNSOM, Assistant Professor of Medicine Geriatrics / Hospice & Palliative Medicine
Delirium A Geriatric Syndrome Jonathan McCaleb, MD, CMD, HMDC UNSOM, Assistant Professor of Medicine Geriatrics / Hospice & Palliative Medicine Introduction Common Serious Unrecognized: a medical emergency
More informationThe treatment of bipolar disorder in adults, children and adolescents
DRAFT FOR CONSULTATION The treatment of bipolar disorder in adults, children and adolescents The paragraphs in the draft are numbered for the purposes of consultation. The final version will not contain
More informationAntipsychotic Medication
Antipsychotic Medication Mary Knutson, RN 3-7-12 Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 1 Clinical Uses of Antipsychotics Short-term: in severe depression and
More informationSwitching antipsychotics: Basing practice on pharmacology & pharmacokinetics
Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics John Donoghue Liverpool L imagination est plus important que le savoir Albert Einstein Switching Antipsychotics: Objectives
More information